Benyoussef Naïmi

521 total citations
10 papers, 390 citations indexed

About

Benyoussef Naïmi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Benyoussef Naïmi has authored 10 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Benyoussef Naïmi's work include Signaling Pathways in Disease (4 papers), Peptidase Inhibition and Analysis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Benyoussef Naïmi is often cited by papers focused on Signaling Pathways in Disease (4 papers), Peptidase Inhibition and Analysis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Benyoussef Naïmi collaborates with scholars based in France, United Kingdom and Spain. Benyoussef Naïmi's co-authors include Samia Mourah, Fabien Calvo, Suzanne Ménashi, Célèste Lebbé, Marie-Pierre Podgorniak, Cathy Quemener, Olivier Cussenot, Éric Gabison, Géraldine Lescaille and G. Millot and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Benyoussef Naïmi

10 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benyoussef Naïmi France	9	317	119	95	92	63	10	390
Lucia Gullotti Germany	6	417 1.3×	85 0.7×	56 0.6×	55 0.6×	96 1.5×	9	533
Chiemi Saigo Japan	11	166 0.5×	94 0.8×	84 0.9×	55 0.6×	94 1.5×	50	362
Anna Zielinska‐Kwiatkowska United States	14	449 1.4×	67 0.6×	83 0.9×	49 0.5×	131 2.1×	17	594
Julien Deheuninck France	7	343 1.1×	110 0.9×	44 0.5×	47 0.5×	50 0.8×	8	455
Quan-Sheng Zhu United States	9	234 0.7×	148 1.2×	39 0.4×	65 0.7×	94 1.5×	9	413
Kazunobu Isogaya Japan	12	427 1.3×	180 1.5×	98 1.0×	34 0.4×	59 0.9×	15	533
Anthony G. Clementz United States	8	321 1.0×	220 1.8×	84 0.9×	28 0.3×	68 1.1×	9	497
Valerie J. Ludbrook United Kingdom	9	152 0.5×	52 0.4×	52 0.5×	114 1.2×	42 0.7×	10	347
Shunlin Jiang United States	10	349 1.1×	104 0.9×	137 1.4×	59 0.6×	41 0.7×	14	499
Ayse Ceren Mutgan Germany	7	152 0.5×	131 1.1×	94 1.0×	70 0.8×	110 1.7×	12	348

Countries citing papers authored by Benyoussef Naïmi

Since Specialization

Citations

This map shows the geographic impact of Benyoussef Naïmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benyoussef Naïmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benyoussef Naïmi more than expected).

Fields of papers citing papers by Benyoussef Naïmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benyoussef Naïmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benyoussef Naïmi. The network helps show where Benyoussef Naïmi may publish in the future.

Co-authorship network of co-authors of Benyoussef Naïmi

This figure shows the co-authorship network connecting the top 25 collaborators of Benyoussef Naïmi. A scholar is included among the top collaborators of Benyoussef Naïmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benyoussef Naïmi. Benyoussef Naïmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Lescaille, Géraldine, Suzanne Ménashi, B. Cavelier‐Balloy, et al.. (2012). EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression. BMC Cancer. 12(1). 115–115. 31 indexed citations

Ménashi, Suzanne, Benyoussef Naïmi, Raphaël Porcher, et al.. (2010). EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2. PLoS ONE. 5(8). e12265–e12265. 32 indexed citations

Paule, Bernard, Laurence Bastien, Olivier Cussenot, et al.. (2010). Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas. PLoS ONE. 5(5). e10715–e10715. 41 indexed citations

Quemener, Cathy, Sabrina Kellouche, Benyoussef Naïmi, et al.. (2009). EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2α–mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood. 114(27). 5547–5556. 95 indexed citations

Mourah, Samia, Raphaël Porcher, Géraldine Lescaille, et al.. (2009). Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia. The International Journal of Biological Markers. 24(1). 22–31. 15 indexed citations

Mourah, Samia, Raphaël Porcher, Géraldine Lescaille, et al.. (2009). Quantification of VEGF Isoforms and VEGFR Transcripts by qRT-PCR and Their Significance in Acute Myeloid Leukemia. The International Journal of Biological Markers. 24(1). 22–31. 12 indexed citations

Quemener, Cathy, Éric Gabison, Benyoussef Naïmi, et al.. (2007). Extracellular Matrix Metalloproteinase Inducer Up-regulates the Urokinase-Type Plasminogen Activator System Promoting Tumor Cell Invasion. Cancer Research. 67(1). 9–15. 71 indexed citations

Naïmi, Benyoussef, Alain Latil, Georges Fournier, et al.. (2002). Down‐regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. The Prostate. 52(3). 245–252. 61 indexed citations

Naïmi, Benyoussef, Andrew Harrison, Upendra Nongthomba, et al.. (2001). A Tropomyosin-2 Mutation Suppresses a Troponin I Myopathy inDrosophila. Molecular Biology of the Cell. 12(5). 1529–1539. 31 indexed citations

10.

Naïmi, Benyoussef, Alain Latil, Philippe Berthon, & Olivier Cussenot. (2000). No evidence for fibroblast growth factor receptor 3 (FGFR‐3) R248C/S249C mutations in human prostate cancer. International Journal of Cancer. 87(3). 455–456. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact